
BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M

BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
Knight launches Minjuvi in Argentina for DLBCL patients
Hemostemix's Boots on the Ground in Florida October Update
Bionxt receives EAPO readiness-to-grant notification
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
Glass House Brands to Host Third Quarter 2025 Earnings Call on November 12, 2025
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
BioNxt Reports "Readiness to Grant" Patent Notification from the Eurasian Patent Organization
Cipher Pharmaceuticals to release Q3 results Nov. 6
Quantum BioPharma Ltd. Announces Corporate Updates
VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements
Ventripoint to test AI-enhanced echocardiography
Bausch Health Announces Third Quarter 2025 Results
XORTX closes $1.1-million (U.S.) direct offering